Clinical Trials Logo

Clinical Trial Summary

The study is a randomized acceptability trial involving the provision of three different doses of Moringa powder to be consumed daily by study participants.


Clinical Trial Description

Moringa is a drought-resistant nutrient-dense tree with high concentrations of anti-inflammatory plant chemicals in its edible leaves and seeds. In preclinical studies Moringa has been shown to improve insulin resistance, dyslipidemia, and high blood pressure. But its effects in humans remain unclear. Moringa (20g leaf powder on two different days) supplementation decreased post-prandial glucose in Saharawi refugees with type 2 diabetes, compared to controls (Leone, et. al., 2018). In a randomized control trial in Spain, Moringa consumed as six daily capsules of dry leaf powder (2.4 g/day) for 12 weeks, significant decreased fasting blood glucose and glycated hemoglobin (HbA1c) among prediabetic subjects (Gomez-Martinez, et. al., 2021). The investigators are conducting a testing trial of Moringa oleifera leaves, offered as powder, to be added to foods and/or drinks to test safety, acceptability and consumption of it in three different doses: 1 tsp, 2 tsp, and 3 tsp. Study participants will be randomly allocated to one of the three doses. Among the studies that have been conducted with human subjects (individuals with diabetes), no adverse effects have been reported with whole leaf powder at up to a single dose of 50 g or using 8 g per day dose for 40 days (Stohs & Hartman, 2015). The outcomes to be measured in this testing trial are the following: - Consumption (measured by self-report and skin carotenoid level, as a biomarker of consumption of fruits and vegetables) - Acceptability (measured by rating the taste of the moringa powder when consumed with foods/drinks) - Safety (measured by self-report of any potential side effects, such as digestive issues due to fiber content) Results from this trial will suggest an acceptable dose in a population not yet diagnosed with a specific disease (e.g. diabetes) and therefore potentially less willing to consume it in doses that could make taste a potential barrier for consumption. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05861076
Study type Interventional
Source University of California, Berkeley
Contact
Status Active, not recruiting
Phase N/A
Start date January 3, 2023
Completion date May 30, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Recruiting NCT06403163 - Transfusion Surveillance in Anaesthesia
Completed NCT04256590 - Tongue Depressor-related Tongue Swelling
Completed NCT04543851 - CARA Treatment Pilot Study for Breast Positioning N/A
Completed NCT04205253 - Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
Completed NCT06133218 - Patient Reported Outcomes Using Mepitel Film During Radiotherapy N/A
Active, not recruiting NCT05155202 - Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit
Not yet recruiting NCT06060886 - Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis Phase 4
Recruiting NCT05055648 - PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy N/A
Completed NCT02146053 - Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron. Early Phase 1
Completed NCT02978846 - Perceptions of Side Effects of Cancer Chemoradiotherapy
Completed NCT03949270 - Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer N/A
Recruiting NCT05958823 - Effects of Serratus Anterior Plan Block (SAP) and Pectoralis Blocks (PECS I-II) After Open Heart Surgery N/A
Completed NCT04506840 - Physical Activity and Motivation in Colorectal Cancer Patients N/A
Completed NCT05421962 - Analgosedation for Elective Colonoscopy Phase 1
Completed NCT04456621 - Proton Beam Therapy for Unresectable Liver Metastasis N/A
Not yet recruiting NCT04066998 - Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With Dupilumab N/A
Completed NCT03530787 - Cosmetic Effects of Topical Acetyl Zingerone N/A
Completed NCT03684993 - Caries Prevention and Side Effects of Gum Arabic and Licorice Extracts Versus Chlorhexidine in High Caries Risk Patients Phase 2/Phase 3
Completed NCT04066153 - Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions